Page 1 of Clinical Trials for Saxagliptin, 58 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Withdrawn
BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States
Last Updated: June 1, 2011
Condition(s): Type 2 Diabetes
2
Completed
Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered
Last Updated: January 9, 2012
Condition(s): Type 2 Diabetes Mellitus
3
Completed
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
Last Updated: April 19, 2011
Condition(s): Diabetes Mellitus
4
Completed
Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants
Last Updated: November 1, 2011
Condition(s): Type 2 Diabetes Mellitus
5
Completed
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
Last Updated: April 19, 2011
Condition(s): Diabetes Mellitus
6
Not yet recruiting
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
Last Updated: April 30, 2012
Condition(s): Type 2 Diabetes Mellitus
7
Completed
Bioequivalence (BE) Study of Fixed Dose Combinations (FDC) of Saxagliptin/Metformin - Brazil
Last Updated: December 8, 2011
Condition(s): Type 2 Diabetes Mellitus
8
Completed
Study in Healthy Subjects to Measure Amount of Drug in Blood After Dosing With Different Saxagliptin / Metformin Produc
Last Updated: February 7, 2012
Condition(s): Bioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and Metformin
9
Completed
Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)
Last Updated: November 7, 2011
Condition(s): Type 2 Diabetes Mellitus
10
Completed
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Last Updated: August 4, 2010
Condition(s): Diabetes
11
Completed
Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (B)
Last Updated: February 22, 2011
Condition(s): Type 2 Diabetes Mellitus
12
Recruiting
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Last Updated: April 30, 2012
Condition(s): Type 2 Diabetes
13
Completed
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Last Updated: August 5, 2011
Condition(s): Diabetes Mellitus, Type 2
14
Not yet recruiting
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Last Updated: April 30, 2012
Condition(s): Diabetes Mellitus, Type 2
15
Not yet recruiting
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
Last Updated: May 24, 2012
Condition(s): Type 2 Diabetes
16
Completed
Study of Multiple Doses of Saxagliptin (BMS-477118)
Last Updated: August 4, 2010
Condition(s): Type 2 Diabetes Mellitus
17
Completed
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone
Last Updated: August 4, 2010
Condition(s): Diabetes Mellitus, Type 2
18
Completed
Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin
Last Updated: July 8, 2009
Condition(s): Type 2 Diabetes
19
Completed
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Last Updated: November 20, 2009
Condition(s): Diabetes
20
Completed
Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects
Last Updated: February 22, 2011
Condition(s): Type 2 Diabetes Mellitus

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Saxagliptin

Page 1 of Clinical Trials for Saxagliptin, 58 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About